Literature DB >> 32362028

Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer.

Ghita Chabab1, Clément Barjon1,2, Naoill Abdellaoui1, Lucie Salvador-Prince1, Cécile Dejou1, Henri-Alexandre Michaud1, Florence Boissière-Michot3, Evelyne Lopez-Crapez1,3, William Jacot1,4, Didier Pourquier5, Nathalie Bonnefoy1, Virginie Lafont1.   

Abstract

γδ T cells contribute to the immune response against many cancers, notably through their powerful effector functions that lead to the elimination of tumor cells and the recruitment of other immune cells. However, their presence in the tumor microenvironment has been associated with poor prognosis in breast, colon, and pancreatic cancer, suggesting that γδ T cells may also display pro-tumor activities. Here, we identified in blood from healthy donors a subpopulation of Vδ1T cells that represents around 20% of the whole Vδ1 population, expresses CD73, and displays immunosuppressive phenotype and functions (i.e., production of immunosuppressive molecules, such as IL-10, adenosine, and the chemotactic factor IL-8, and inhibition of αβ T cell proliferation). We then found that in human breast tumors, γδ T cells were present particularly in late stage breast cancer samples, and that ∼20% of tumor-infiltrating γδ T cells expressed CD73. Taken together, these results suggest that regulatory γδ T cells are present in the breast cancer microenvironment and may display immunosuppressive functions through the production of immunosuppressive molecules, such as IL-10, IL-8, and adenosine, thus promoting tumor growth. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  immunosuppression; non-conventional T cells; tumor microenvironment

Year:  2020        PMID: 32362028     DOI: 10.1002/JLB.3MA0420-278RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73.

Authors:  Ross J Turner; Nicholas J Geraghty; Jonathan G Williams; Diane Ly; Daniel Brungs; Martin G Carolan; Thomas V Guy; Debbie Watson; Jeremiah F de Leon; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2020-08-05       Impact factor: 3.765

2.  TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets.

Authors:  Bernardo S Reis; Patrick W Darcy; Iasha Z Khan; Christine S Moon; Adam E Kornberg; Vanessa S Schneider; Yelina Alvarez; Olawale Eleso; Caixia Zhu; Marina Schernthanner; Ainsley Lockhart; Aubrey Reed; Juliana Bortolatto; Tiago B R Castro; Angelina M Bilate; Sergei Grivennikov; Arnold S Han; Daniel Mucida
Journal:  Science       Date:  2022-07-14       Impact factor: 63.714

Review 3.  Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There?

Authors:  Norihiro Watanabe; Maksim Mamonkin
Journal:  Cancer J       Date:  2021 Mar-Apr 01       Impact factor: 3.360

4.  Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers.

Authors:  Ghita Chabab; Florence Boissière-Michot; Caroline Mollevi; Jeanne Ramos; Evelyne Lopez-Crapez; Pierre-Emmanuel Colombo; William Jacot; Nathalie Bonnefoy; Virginie Lafont
Journal:  Cells       Date:  2020-06-24       Impact factor: 6.600

Review 5.  Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring "Universal" Donor T Cells.

Authors:  Cynthia Perez; Isabelle Gruber; Caroline Arber
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

Review 6.  Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy.

Authors:  Ghita Chabab; Clément Barjon; Nathalie Bonnefoy; Virginie Lafont
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

7.  Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion.

Authors:  Stéphane Fattori; Laurent Gorvel; Samuel Granjeaud; Philippe Rochigneux; Marie-Sarah Rouvière; Amira Ben Amara; Nicolas Boucherit; Magali Paul; Marie Mélanie Dauplat; Jeanne Thomassin-Piana; Maria Paciencia-Gros; Morgan Avenin; Jihane Pakradouni; Julien Barrou; Emmanuelle Charafe-Jauffret; Gilles Houvenaeghel; Eric Lambaudie; François Bertucci; Anthony Goncalves; Carole Tarpin; Jacques A Nunès; Raynier Devillier; Anne-Sophie Chretien; Daniel Olive
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

Review 8.  Gamma Delta T Cells and Their Pathogenic Role in Psoriasis.

Authors:  Cong Qi; Yazhuo Wang; Ping Li; Jingxia Zhao
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 9.  Cancer immunotherapy with γδ T cells: many paths ahead of us.

Authors:  Dieter Kabelitz; Ruben Serrano; Léonce Kouakanou; Christian Peters; Shirin Kalyan
Journal:  Cell Mol Immunol       Date:  2020-07-22       Impact factor: 11.530

Review 10.  Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.

Authors:  Priscila Ferreira Slepicka; Mahboubeh Yazdanifar; Alice Bertaina
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.